from2028 Activists Investors Trump Politicians Serenity Citrini Semianalysis Trade Arbitrage Search

$GMAB:NASDAQ · GENMAB A/S

Conviction from: NASDAQ

Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL), large B-cell ly

Not currently held by tracked 13F filers — this page aggregates activist, insider, politician and research activity.

Beyond 13F — activists, insiders, politicians & research

Congressional trades all politician trades →

1 disclosed trade(s) by 1 filer(s).

Trade date	Who	Type	Amount
2026-03-30	Alan Armstrong senate	BUY	$1,001 - $15,000	PTR

from2028 — cross-site stock view. Rebuilt at publish time.